ABN AMRO Investment Solutions’s Twist Bioscience TWST Stock Holding History

ABN AMRO Investment Solutions’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$621K	Buy	+6,035	New	+$393K	0.01%	578

Other funds holding TWST

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

ABN AMRO Investment Solutions's TWST Position: Q2 2026 in Review

ABN AMRO Investment Solutions opened a new position in Twist Bioscience (TWST) in Q2 2026: 6,035 shares worth $621K. The stake represents 0.01% of the portfolio and ranks #578 among its holdings.

33 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

ABN AMRO Investment Solutions held 6,035 shares of Twist Bioscience worth $621K as of Q2 2026.
Twist Bioscience was a new ABN AMRO Investment Solutions position in Q2 2026.
Twist Bioscience made up 0.01% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #578 holding.
33 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.